Nalaganje...

Can Controlling Endoplasmic Reticulum Dysfunction Treat Allergic Inflammation in Severe Asthma With Fungal Sensitization?

Severe asthma is a heterogeneous disease entity to which diverse cellular components and pathogenetic mechanisms contribute. Current asthma therapies, including new biologic agents, are mainly targeting T helper type 2 cell-dominant inflammation, so that they are often unsatisfactory in the treatmen...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Allergy Asthma Immunol Res
Main Authors: Jeong, Jae Seok, Kim, So Ri, Lee, Yong Chul
Format: Artigo
Jezik:Inglês
Izdano: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2018
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5809759/
https://ncbi.nlm.nih.gov/pubmed/29411551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4168/aair.2018.10.2.106
Oznake: Označite
Brez oznak, prvi označite!